Sign in
8-K

Current Report

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-19-170256

Executive or director change · Shareholder vote results

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d742816d8k.htm…